Fundraising Fox

Prometheus Therapeutics

Miramar, US · Delaware corporation

Founders & leadership

BN
Bernie NavarroExecutive
BL
Baruch LieberNamed on SEC filing
AW
Ajay WakhlooNamed on SEC filing
ML
Marc LitzenbergNamed on SEC filing

Board

AH
Alexander HastingsBoard director
JM
John McEleneyBoard director

Reported raises · per SEC filings

Form D private placements

$11.6M disclosed across 4 rounds · 2020–2025

$2.7MraisedApr 2026 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander HastingsDirector
  • Bernie NavarroExecutive Officer
  • Baruch LieberExecutive Officer, Director
  • Ajay WakhlooExecutive Officer, Director
  • John McEleneyDirector
Offering amount
$6.5M
Amount sold
$2.7M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$8.2MraisedJun 2024 · 46 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ajay WakhlooExecutive Officer, Director
  • Marc LitzenbergExecutive Officer, Director
  • Baruch LieberExecutive Officer, Director
  • Bernardo NavarroExecutive Officer
Offering amount
$8.4M
Amount sold
$8.2M
Finders' fees
$250K
Placement agents
Andrew Bazarian, Christopher Lear, Elliot Sax
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$345KraisedJul 2022 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bernardo NavarroExecutive Officer
  • Ajay WakhlooExecutive Officer, Director
  • Baruch LieberExecutive Officer, Director
  • Marc LitzenbergExecutive Officer, Director
Offering amount
$345K
Amount sold
$345K
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$287.1KraisedSep 2020 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc LitzenbergExecutive Officer, Director
  • Baruch LieberExecutive Officer, Director
  • Bernardo NavarroExecutive Officer
  • Ajay WakhlooExecutive Officer, Director
Offering amount
$697.2K
Amount sold
$287.1K
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Prometheus Therapeutics raised?
Prometheus Therapeutics has disclosed $11.6M raised across 4 rounds.
Where is Prometheus Therapeutics headquartered?
Prometheus Therapeutics is headquartered in Miramar, US.